Fact CheckerSign in

NCT06223828RecruitingPhase 2/3

Azithromycin for Critical Asthma - Pediatrics

Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking

Source: ClinicalTrials.gov · Last updated 11 Aug 2026

Brief summary (registry, in English)

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
100 (estimated)
First submitted
16 Jan 2024
Start date
2 Apr 2024
Primary completion date
31 Dec 2026
Lead sponsor
Johns Hopkins All Children's Hospital
Diseases
Asthma
NCT number
NCT06223828

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 100
  • From 2 Apr 2024 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concomitant respiratory pathology including Acute Chest Syndrome, Interstitial Lung Disease, Cystic Fibrosis, and pulmonary hypertension

Other illness

  • Critical Congenital Heart Disease Unrepaired

Lab values

  • Past Medical History of Prolonged QT Syndrome or Arrhythmias

Other

  • Tracheostomy Dependence at Admission
  • Ongoing Exposure to Azithromycin or Macrolide Antibiotics for any indication

Who the study is looking for

  • Age 3-17 years
  • Admission to the PICU
  • Primary diagnosis of critical asthma
  • Prescription for continuous inhaled beta-agonist therapy and/or intravenous (IV) beta-agonist therapy
  • Prescription for intravenous systemic corticosteroids

Age in the registry: 3 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins All Children's Hospital
Coordinator of this site? Confirm its status
St. PetersburgUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.